MedTrace Logo

Developing and Implementing a Quality Measure for Glycemic Control

NCT00012675 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2012-05-24

No results posted yet for this study

Summary

Many patients with diabetes are under sub-optimal glycemic control. Central to the clinician's task in improving glycemic control is the management of hypoglycemic medication therapy, including the use of drugs such as insulin and sulfonylureas. Clinical trials have demonstrated that more intensive hypoglycemic medication therapy results in improved glycemic control. Yet quality measures for this critical process of care have not been developed and we know little about how physicians actually manage hypoglycemic medications.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dan R. Berlowitz, MD MPH · Bedford VA Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2003-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00012675 on ClinicalTrials.gov